Literature DB >> 17093188

The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription.

Humayra Ali1, Gary LeRoy, Gemma Bridge, S J Flint.   

Abstract

The adenovirus late IVa2 protein is required for maximally efficient transcription from the viral major late (ML) promoter, and hence, the synthesis of the majority of viral late proteins. This protein is a sequence-specific DNA-binding protein that also promotes the assembly of progeny virus particles. Previous studies have established that a IVa2 protein dimer (DEF-B) binds specifically to an intragenic ML promoter sequence necessary for late phase-specific stimulation of ML transcription. However, activation of transcription from the ML promoter correlates with binding of at least one additional infected-cell-specific protein, termed DEF-A, to the promoter. Using an assay for the DNA-binding activity of DEF-A, we identified the unknown protein by using conventional purification methods, purification of FLAG-tagged IVa2-protein-containing complexes, and transient synthesis of viral late proteins. The results of these experiments established that the viral L4 33-kDa protein is the only component of DEF-A: the IVa2 and L4 33-kDa proteins are necessary and sufficient for formation of all previously described complexes in the intragenic control region of the ML promoter. Furthermore, the L4 33-kDa protein binds to the promoter with the specificity characteristic of DEF-A and stimulates transcription from the ML promoter in transient-expression assays.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093188      PMCID: PMC1797539          DOI: 10.1128/JVI.01584-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo.

Authors:  Almudena Pardo-Mateos; C S H Young
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

3.  Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride.

Authors:  J F Williams
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

4.  The major late adenovirus type-2 transcription unit: termination is downstream from the last poly(A) site.

Authors:  N W Fraser; J R Nevins; E Ziff; J E Darnell
Journal:  J Mol Biol       Date:  1979-04-25       Impact factor: 5.469

5.  Phosphoproteins of adenovirus 2.

Authors:  N Axelrod
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

6.  Identification of a cellular repressor of transcription of the adenoviral late IVa(2) gene that is unaltered in activity in infected cells.

Authors:  H J Lin; S J Flint
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

7.  Role for the adenovirus IVa2 protein in packaging of viral DNA.

Authors:  W Zhang; J A Low; J B Christensen; M J Imperiale
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Polypeptide phosphorylation in adenovirus-infected cells.

Authors:  W C Russell; G E Blair
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

9.  Ternary complex formation between DNA-adenovirus core protein VII and TAF-Ibeta/SET, an acidic molecular chaperone.

Authors:  Hirohito Haruki; Bela Gyurcsik; Mitsuru Okuwaki; Kyosuke Nagata
Journal:  FEBS Lett       Date:  2003-12-18       Impact factor: 4.124

10.  Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products.

Authors:  Daniel C Farley; Jason L Brown; Keith N Leppard
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more
  24 in total

1.  Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome.

Authors:  Baoling Ying; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Adenovirus late-phase infection is controlled by a novel L4 promoter.

Authors:  Susan J Morris; Gillian E Scott; Keith N Leppard
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging.

Authors:  Beverly P Wohl; Patrick Hearing
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

4.  Presence of the adenovirus IVa2 protein at a single vertex of the mature virion.

Authors:  Joan B Christensen; Serena A Byrd; Angela K Walker; John R Strahler; Philip C Andrews; Michael J Imperiale
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

5.  Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression.

Authors:  Susan J Morris; Keith N Leppard
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

6.  Ternary complex formation on the adenovirus packaging sequence by the IVa2 and L4 22-kilodalton proteins.

Authors:  Sean G Ewing; Serena A Byrd; Joan B Christensen; Ryan E Tyler; Michael J Imperiale
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  Structures of Adenovirus Incomplete Particles Clarify Capsid Architecture and Show Maturation Changes of Packaging Protein L1 52/55k.

Authors:  Gabriela N Condezo; Roberto Marabini; Silvia Ayora; José M Carazo; Raúl Alba; Miguel Chillón; Carmen San Martín
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

8.  The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection.

Authors:  Kai Wu; Diana Orozco; Patrick Hearing
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

9.  Role of the RNA recognition motif of the E1B 55 kDa protein in the adenovirus type 5 infectious cycle.

Authors:  Sayuri E M Kato; Wenying Huang; S J Flint
Journal:  Virology       Date:  2011-05-24       Impact factor: 3.616

10.  Identification and characterization of a DNA binding domain on the adenovirus IVa2 protein.

Authors:  Joan B Christensen; Sean G Ewing; Michael J Imperiale
Journal:  Virology       Date:  2012-08-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.